CRITICAL INNOVATIONS LLC — Department of Defense SBIR Phase II: DHA SBIR SEQUENTIAL PHASE II RESEARCH AND DEVELOPMENT CONTRACT, PROPOSAL TITLED: "DONALDSO
CRITICAL INNOVATIONS LLC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,300,000 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Critical Innovations LLC received a $1.3 million DoD SBIR Phase II award to develop an automated decompression needle for treating tension pneumothorax, a dangerous buildup of air in the chest cavity. The project focuses on creating the Donaldson Decompression Needle to enable fast, reliable emergency treatment for military medical needs.
- Amount
- $1,300,000
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- CA
- Period
- 2024-08-07 → 2027-01-11
Technology domains
Description
DHA SBIR SEQUENTIAL PHASE II RESEARCH AND DEVELOPMENT CONTRACT, PROPOSAL TITLED: "DONALDSON DECOMPRESSION NEEDLE FOR AUTOMATED TREATMENT OF TENSION PNEUMOTHORAX"